Palatin Technologies Inc Receivables Turnover Ratio (PTN), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Palatin Technologies Inc   (NYSEAMER: PTN)
 

Palatin Technologies Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Palatin Technologies Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 4.8, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Palatin Technologies Inc in Mar 31 2026 quarter, has decreased to 76 days, compared to 90 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector Palatin Technologies Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Palatin Technologies Inc Selling?


What is Receivable Turnover Ratio?





PTN Receivables Turnover Ratio (Mar 31 2026)
III. Quarter
(Dec 31 2025)
II. Quarter
(Sep 30 2025)
I. Quarter
(Jun 30 2025)
IV. Quarter
(Mar 31 2025)
III. Quarter
Y / Y Receivable Change 699.6 % - - - -
Y / Y Revenue Change - - - - -
Receivable Turnover Ratio (TTM) 4.8 4.05 4.91 - 5.17
PTN's Total Ranking # # # # #
Accounts Receivable average collection period days 76 90 74 - 71
Seq. Receivable Change 32.44 % -76.31 % 23336.36 % -89.13 % -
Seq. Revenue Change 3278.84 % -98.69 % - - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 






Financial Statements
Palatin Technologies Inc 's Accounts Receivable $ 2 Millions Visit PTN's Balance sheet
Palatin Technologies Inc 's Sales TTM $ 13 Millions Visit PTN's Income Statement
Sources of PTN's Revenues Visit PTN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PTN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PTN's Growth Rates PTN's Roa PTN's Inventory Turnover Ratio PTN's Dividend Comparisons
PTN's Profitability Ratios PTN's Roi PTN's Asset Turnover Ratio PTN's Dividend Growth
PTN's Valuation Ratios PTN's Roe PTN's Financial Strength Ratios PTN's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026
Premier Air Charter Holdings Inc   16.33 $ 33.205  Millions$ 2.033  Millions
Bioage Labs Inc   15.90 $ 10.316  Millions$ 0.649  Millions
Nurix Therapeutics Inc   15.11 $ 71.779  Millions$ 4.750  Millions
Lexicon Pharmaceuticals Inc   14.91 $ 69.643  Millions$ 4.670  Millions
Qhslab Inc   14.80 $ 2.775  Millions$ 0.188  Millions
Nexgel Inc   14.19 $ 10.382  Millions$ 0.732  Millions
Sutro Biopharma Inc   14.04 $ 99.608  Millions$ 7.095  Millions
Precipio inc   13.93 $ 25.831  Millions$ 1.854  Millions
China Pharma Holdings Inc  13.86 $ 3.992  Millions$ 0.288  Millions
Talkspace Inc   13.67 $ 239.269  Millions$ 17.501  Millions
Marpai Inc  13.59 $ 17.125  Millions$ 1.261  Millions
Amneal Pharmaceuticals Inc   13.56 $ 3,045.530  Millions$ 224.634  Millions
Corcept Therapeutics Inc  13.20 $ 769.096  Millions$ 58.264  Millions
Rosecliff Acquisition Corp I  13.19 $ 20.547  Millions$ 1.557  Millions
Xoma Royalty Corporation  13.05 $ 48.555  Millions$ 3.720  Millions
Mannkind Corporation  13.00 $ 360.783  Millions$ 27.757  Millions
Lifestance Health Group Inc   12.74 $ 1,494.791  Millions$ 117.296  Millions
Chemed Corporation  12.73 $ 2,540.548  Millions$ 199.626  Millions
Milestone Scientific Inc   12.69 $ 8.337  Millions$ 0.657  Millions
Lftd Partners Inc   12.55 $ 36.955  Millions$ 2.945  Millions
Clene Inc   12.47 $ 0.134  Millions$ 0.011  Millions
Skinhealth Systems Inc   12.27 $ 295.223  Millions$ 24.052  Millions
Cytokinetics Incorporated  12.16 $ 105.815  Millions$ 8.702  Millions
Precision Biosciences Inc  11.94 $ 45.073  Millions$ 3.776  Millions
Teladoc Health Inc   11.94 $ 2,514.453  Millions$ 210.660  Millions
Option Care Health Inc   11.65 $ 5,666.577  Millions$ 486.439  Millions
Ensysce Biosciences Inc   11.55 $ 4.708  Millions$ 0.407  Millions
Crinetics Pharmaceuticals Inc   11.52 $ 18.069  Millions$ 1.569  Millions
Icu Medical Inc  11.46 $ 2,156.379  Millions$ 188.157  Millions
Nrc Health  11.42 $ 138.642  Millions$ 12.138  Millions

Date modified: 2026-08-30T14:38:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.